belfasttelegraph Monday, 2 March, 2015

Gilead Sciences, Inc.

Gilead Sciences, Inc.

Search news from around the web

  1. Nomura’s M. Ian Somaiya believes Gilead Sciences’ (GILD) “HIV succession plan [is] coming into focus.” He explains: Sipa USA/Associated Press We reiterate our Buy rating and $141 TP ... FULL ARTICLE AT Barron's

  2. Puma Biotechnology (PBYI) is target of a perennial buy-out speculation, and with biotech acquisitions once again in the news, UBS analyst Matthew Roden and team consider potential acquirers, including Gilead ... FULL ARTICLE AT Barron's

  1. Fast Track designation of two new proprietary DepoVax programs for critical diseases and comprehensive long-term agreement with major pharmaceutical company advances Immunovaccine's pipeline and significantly strengthen's company's ... FULL ARTICLE AT Emediawire.com

  2. Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Gilead+Sciences+%28GILD%29+Reports+Significant+Data+from+Elvitegravir+Combo+Phase+3s+vs.+Stribild/10320781.html for the full story. FULL ARTICLE AT Street Insider

  3. Gilead Sciences Inc., whose $1,000-a-pill hepatitis C treatment is one of the world's most expensive drugs, is avoiding billions of dollars in U.S. taxes by booking profits ... FULL ARTICLE AT Bradenton Herald

  1. Gilead Sciences Inc., whose $1,000-a-pill hepatitis C treatment is one of the world’s most expensive drugs, is avoiding billions of dollars in taxes by booking profit overseas. The ... FULL ARTICLE AT San Francisco Chronicle

  2. Drugmaker Bristol-Myers Squibb Co. said Thursday that an experimental combination of two hepatitis C drugs — its daclatasvir and Gilead Sciences Inc.'s blockbuster drug Sovaldi — cured hepatitis C in just ... FULL ARTICLE AT FOX Business

  3. Drugmaker Bristol-Myers Squibb Co. said Thursday that an experimental combination of two hepatitis C drugs — its daclatasvir and Gilead Sciences Inc.'s blockbuster drug Sovaldi — cured hepatitis C in just ... FULL ARTICLE AT FOX Business

  4. Ninety-seven percent of hepatitis C patients also infected with HIV were cured of the liver-destroying virus after 12 weeks of treatment with Bristol-Myers Squibb's daclatasvir and Gilead Sciences' Sovaldi ... FULL ARTICLE AT Channel News Asia

About this topic

Wikipedia

Gilead Sciences (NASDAQ: GILD) is a biopharmaceutical company that discovers, develops and commercializes therapeutics. For many years since the company was founded, the company concentrated primarily on antiviral drugs to treat patients infected with HIV, hepatitis B or influenza. In 2006, Gilead acquired two companies that were developing drugs to treat patients with pulmonary diseases. The... Full Article At Wikipedia.org

Timeline of coverage

  1. Click to see all coverage from 2015-01-16
    2015-01-16
  2. Click to see all coverage from 2015-01-17
    2015-01-17
  3. Click to see all coverage from 2015-01-18
    2015-01-18
  4. Click to see all coverage from 2015-01-19
    2015-01-19
  5. Click to see all coverage from 2015-01-20
    2015-01-20
  6. Click to see all coverage from 2015-01-21
    2015-01-21
  7. Click to see all coverage from 2015-01-22
    2015-01-22
  8. Click to see all coverage from 2015-01-23
    2015-01-23
  9. Click to see all coverage from 2015-01-24
    2015-01-24
  10. Click to see all coverage from 2015-01-25
    2015-01-25
  11. Click to see all coverage from 2015-01-26
    2015-01-26
  12. Click to see all coverage from 2015-01-27
    2015-01-27
  13. Click to see all coverage from 2015-01-28
    2015-01-28
  14. Click to see all coverage from 2015-01-29
    2015-01-29
  15. Click to see all coverage from 2015-01-30
    2015-01-30
  16. Click to see all coverage from 2015-01-31
    2015-01-31
  17. Click to see all coverage from 2015-02-01
    2015-02-01
  18. Click to see all coverage from 2015-02-02
    2015-02-02
  19. Click to see all coverage from 2015-02-03
    2015-02-03
  20. Click to see all coverage from 2015-02-04
    2015-02-04
  21. Click to see all coverage from 2015-02-05
    2015-02-05
  22. Click to see all coverage from 2015-02-06
    2015-02-06
  23. Click to see all coverage from 2015-02-07
    2015-02-07
  24. Click to see all coverage from 2015-02-08
    2015-02-08
  25. Click to see all coverage from 2015-02-09
    2015-02-09
  26. Click to see all coverage from 2015-02-10
    2015-02-10
  27. Click to see all coverage from 2015-02-11
    2015-02-11
  28. Click to see all coverage from 2015-02-12
    2015-02-12
  29. Click to see all coverage from 2015-02-13
    2015-02-13
  30. Click to see all coverage from 2015-02-14
    2015-02-14
  31. Click to see all coverage from 2015-02-15
    2015-02-15
  32. Click to see all coverage from 2015-02-16
    2015-02-16
  33. Click to see all coverage from 2015-02-17
    2015-02-17
  34. Click to see all coverage from 2015-02-18
    2015-02-18
  35. Click to see all coverage from 2015-02-19
    2015-02-19
  36. Click to see all coverage from 2015-02-20
    2015-02-20
  37. Click to see all coverage from 2015-02-21
    2015-02-21
  38. Click to see all coverage from 2015-02-22
    2015-02-22
  39. Click to see all coverage from 2015-02-23
    2015-02-23
  40. Click to see all coverage from 2015-02-24
    2015-02-24
  41. Click to see all coverage from 2015-02-25
    2015-02-25
  42. Click to see all coverage from 2015-02-26
    2015-02-26
  43. Click to see all coverage from 2015-02-27
    2015-02-27
  44. Click to see all coverage from 2015-02-28
    2015-02-28
  45. Click to see all coverage from 2015-03-01
    2015-03-01
  46. Click to see all coverage from 2015-03-02
    2015-03-02

Login

Login to make editorial changes to the current page.

Login Cancel

Close